27/11/2025
Excited to announce our latest collaborative publication with Dr. Zaida Díaz Cabiale’s team at the Instituto de Investigación Biomédica de Málaga!
At MEDINA’s preclinical platform, we carried out key ADME tox studies on a promising candidate drug for depression and alcohol use disorders. Results showed:
✅ No adverse effects on cardiac function
✅ No genotoxicity
✅ Minimal interaction with CYP450 enzymes
These findings strongly support its suitability for further drug development.
Huge thanks to our collaborators for trusting MEDINA to help advance this drug toward the clinic!
https://www.frontiersin.org/articles/10.3389/fphar.2025.1719440
Frontiers-Pharmacology, Toxicology and Drugs IBIMA Plataforma BIONAND Universidad de Granada Fundación MEDINA MSD España Junta de Andalucía
IntroductionGalanin is a neuropeptide in the central nervous system that regulates mood and alcohol consumption. Its N-terminal fragment, Galanin (1–15) [GAL...